Registry of the German CLL Study Group

Launched by GERMAN CLL STUDY GROUP · Aug 8, 2016

Keywords

ClinConnect Summary

The German CLL Study Group is conducting a clinical trial to keep track of patients with various types of blood cancers, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and others like hairy cell leukemia and Richter's transformation. This long-term study aims to understand how these conditions progress over time and how different treatments affect patients. If you are 18 years or older and have been diagnosed with one of these blood cancers, you may be eligible to participate, especially if you are newly diagnosed, undergoing treatment, or dealing with a relapse.

Participants in this study will be asked to provide consent and share information about their health and treatment history. The trial is currently recruiting patients of all genders, and while it does not require immediate treatment, it offers a chance for patients to be part of a larger effort to improve care for blood cancer. It’s important to note that patients with certain medical issues, like severe brain problems or those who cannot make legal decisions for themselves, cannot participate. This study is a great opportunity to contribute to important research that may help others in the future.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria (all must apply)
• • 1. Confirmed diagnosis of CLL, B-PLL, T-PLL, SLL, T or NK-LGL, HCL or Richter's transformation
• • 2. 18 years of age or older
• • 3. Signed, written informed consent
• 4. Presence of one or more of the following disease situations:
• • Newly diagnosed patients without treatment indication (eligible for watch and wait Approach Treatment within a clinical trial according to the AMG or status post participation in a clinical Trial)
• • Treatment with standard therapies approved for the eligible entities or status post treatment (outside of clinical trials)
• • Referral for evaluation the indication for HSCT
• • Relapsed disease status (even if first diagnosis was prior to activation of the registry)
• • Exclusion Criteria
• • 1. Patients without confirmed diagnosis of CLL, B-PLL, T-PLL, SLL, T or NK- LGL, HCL or Richter's transformation
• • 2. Cerebral dysfunction, legal incapacity